Recruiting
Phase 1
Phase 2

Pembrolizumab with Chemo

Sponsor:

Vanderbilt-Ingram Cancer Center

Code:

NCT05501665

Conditions

Lung Non-Small Cell Carcinoma

Stage IV Lung Cancer AJCC v8

Stage III Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Carboplatin

Computed Tomography

Fludeoxyglucose F-18

Nab-paclitaxel

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by Vanderbilt-Ingram Cancer Center on 2024-10-17.